ARCA biopharma Inc.

2.97-0.1500-4.81%Vol 91.89K1Y Perf -54.98%
Jul 23rd, 2021 16:00 DELAYED
BID2.93 ASK2.99
Open3.15 Previous Close3.12
Pre-Market- After-Market2.99
 - -  0.02 0.67%
Target Price
2.00 
Analyst Rating
— 0.00
Potential %
-32.66 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
100/100/100 
Value Ranking
 —    -
Insiders Value % 3/6/12 mo.
100/100/100 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12 mo.
100/100/100 
Income Ranking
 —    -
Market Cap42.80M 
Earnings Rating
Buy
Price Range Ratio 52W %
5.36 
Earnings Date
4th Aug 2021

Today's Price Range

2.953.17

52W Range

2.727.38

5 Year PE Ratio Range

-1.00-1.10

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Week
2.41%
1 Month
-16.10%
3 Months
-16.10%
6 Months
-36.27%
1 Year
-54.98%
3 Years
-71.55%
5 Years
-0.67%
10 Years
-95.50%

TickerPriceChg.Chg.%
ABIO2.97-0.1500-4.81
AAPL148.561.76001.20
GOOG2 756.3289.75003.37
MSFT289.673.53001.23
XOM57.04-0.0700-0.12
WFC44.59-0.4400-0.98
JNJ171.791.81001.06
FB369.7918.60005.30
GE12.710.01000.08
JPM150.64-0.2900-0.19
Earnings HistoryEstimateReportedSurprise %
Q01 2021--0.33-
Q04 2020--0.61-
Q03 2020--0.33-
Q02 2020--0.73-
Q01 2020--0.83-
Q04 2019--0.69-
Q03 2019--0.76-
Q02 2019--1.14-
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date4th Aug 2021
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume91.89K
Shares Outstanding14.41M
Trades Count644
Dollar Volume3.95M
Avg. Volume598.60K
Avg. Weekly Volume193.11K
Avg. Monthly Volume273.13K
Avg. Quarterly Volume253.46K

ARCA biopharma Inc. (NASDAQ: ABIO) stock closed at 2.97 per share at the end of the most recent trading day (a -4.81% change compared to the prior day closing price) with a volume of 92.13K shares and market capitalization of 42.80M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 20 people. ARCA biopharma Inc. CEO is Michael R. Bristow.

The one-year performance of ARCA biopharma Inc. stock is -54.98%, while year-to-date (YTD) performance is -25.94%. ABIO stock has a five-year performance of -0.67%. Its 52-week range is between 2.72 and 7.38, which gives ABIO stock a 52-week price range ratio of 5.36%

ARCA biopharma Inc. currently has a PE ratio of -1.50, a price-to-book (PB) ratio of 0.63, a price-to-sale (PS) ratio of -, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -52.21%, a ROC of -46.10% and a ROE of -55.65%. The company’s profit margin is -%, its EBITDA margin is -%, and its revenue ttm is $0.00 , which makes it $- revenue per share.

Of the last four earnings reports from ARCA biopharma Inc., there were 0 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.00 for the next earnings report. ARCA biopharma Inc.’s next earnings report date is 04th Aug 2021.

The consensus rating of Wall Street analysts for ARCA biopharma Inc. is (0), with a target price of $2, which is -32.66% compared to the current price. The earnings rating for ARCA biopharma Inc. stock is Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

ARCA biopharma Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

ARCA biopharma Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 12.91, ATR14 : 0.20, CCI20 : -79.96, Chaikin Money Flow : 0.12, MACD : -0.14, Money Flow Index : 51.33, ROC : -20.59, RSI : 39.19, STOCH (14,3) : 24.27, STOCH RSI : 0.51, UO : 46.15, Williams %R : -75.73), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of ARCA biopharma Inc. in the last 12-months were: Robert E. Conway (Buy at a value of $189 222)

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0
0 (0.00 %)
Moderate Buy
0
0
1 (100.00 %)
Hold
0
0
0 (0.00 %)
Moderate Sell
0
0
0 (0.00 %)
Strong Sell
0
0
0 (0.00 %)
Summary Rating--Moderate Buy
2.00

ARCA biopharma Inc.

CEO: Michael R. Bristow

Telephone: +1 720 940-2200

Address: 11080 CirclePoint Road, Westminster 80020, CO, US

Number of employees: 20

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

86%14%

Bearish Bullish

62%38%

Bearish Bullish

57%43%

News

Stocktwits